News

Heptares Therapeutics (Heptares) has entered into an option agreement with the Novartis Option Fund. As per the deal, Heptares will apply its proprietary StaR technology to generate novel

ImmuneRegen BioSciences (ImmuneRegen), a wholly-owned subsidiary of IR Biosciences, has initiated a study utilising the highly pathogenic H5N1-Clade 2 virus to test the efficacy of its lead anti-influenza

Ablynx has reached a settlement with Domantis, part of the GlaxoSmithKline group of companies, concerning an alleged dispute relating to a settlement agreement which Ablynx and Domantis entered

TCGRx (TCG) has entered into a strategic partnership with NetRx. Reportedly, the partnership aligns NetRx with TCG’s expertise in pharmacy workflow solutions; designing automation integration into every aspect

goBalto.com has introduced a new project management tool – Projects, to help professionals organise and run drug-development collaborations. The Web-based tool builds on goBalto’s past implementation of collaborative

Prolifiq has entered into a partnership with EthicsPoint.Together, the companies will offer an important layer of compliance monitoring to help life sciences companies cope with the myriad of

A-Life Medical is releasing its new reconciliation solution, RecoverIt, that is expected to be launched during the Radiology Business Management Association (RBMA) 2009 Fall Educational Conference. The company

VirtualHealth Technologies has reported that its subsidiary Secure eHealth has entered into an agreement with Wound Care Innovations, a subsidiary of Wound Management Technologies, to license out its

BioScience Laboratories and Synomics Pharmaceutical have reported their formal partnership to provide a fully integrated phase 1 clinical study capability for trials in healthy human subjects. The objective